Maravai LifeSciences Holdings, Inc. (MRVI)
NASDAQ: MRVI · Real-Time Price · USD
4.110
+0.160 (4.05%)
At close: Feb 21, 2025, 4:00 PM
4.150
+0.040 (0.97%)
After-hours: Feb 21, 2025, 5:52 PM EST
MRVI Employees
Maravai LifeSciences Holdings had 650 employees as of December 31, 2023. The number of employees increased by 40 or 6.56% compared to the previous year.
Employees
650
Change (1Y)
40
Growth (1Y)
6.56%
Revenue / Employee
$426,031
Profits / Employee
-$345,631
Market Cap
1.04B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 650 | 40 | 6.56% |
Dec 31, 2022 | 610 | 140 | 29.79% |
Dec 31, 2021 | 470 | 60 | 14.63% |
Dec 31, 2020 | 410 | - | - |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 72,000 |
MRVI News
- 18 days ago - TriLink BioTechnologies® and Aldevron Enter into Non-exclusive License and Supply Agreement for CleanCap® mRNA Capping Technology - Business Wire
- 19 days ago - TriLink BioTechnologies® Partners with Avantor® to Expand Nucleic Acid Solutions in Europe - Business Wire
- 6 weeks ago - Maravai LifeSciences Announces Preliminary Unaudited 2024 Revenue - GlobeNewsWire
- 2 months ago - Maravai LifeSciences Appoints R. Andrew Eckert as Chairman of the Board of Directors - GlobeNewsWire
- 3 months ago - Maravai LifeSciences Announces November 2024 Investor Conference Schedule - GlobeNewsWire
- 3 months ago - Maravai LifeSciences Holdings, Inc. (MRVI) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Maravai LifeSciences Plans to Acquire DNA and RNA Business of Officinae Bio, Advancing Support for Innovative Nucleic Acid Research - Business Wire
- 4 months ago - Maravai LifeSciences To Host Earnings Conference Call on Thursday, November 7, 2024 - GlobeNewsWire